HSPB1 and osteosarcoma: Santiago-O'Farrill et al. [39] evaluated p-HSP27 and its correlation with autophagy-induced chemotherapy on osteosarcoma cells lines; according with their results, authors suggested that p-HSP27 could be a beneficial predictive biomarker for combination therapies for osteosarcoma patients.